and DUBLIN, April 15, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company WALTHAM, Mass and DUBLIN, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Mural ...

Were the architect prophets of modernism around today, they no doubt would be dismayed to witness the ongoing classical revival, in evidence most recently and significantly in Robert A. M. Stern ...

Find the latest Mural Oncology plc MURA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.